MagBiosense

MagBiosenseMagBiosense
M

MagBiosense

Developing a point-of-care device and proprietary consumable cartridge for highly sensitive detection of biomarkers using Magnetic Modulation Biosensing (MMB) technique.

DR 282013ActiveSan Diego, United States
Rate

About

MagBiosense is focused on creating advanced diagnostic tools for rapid and highly sensitive detection of biomarkers. Their core technology, Magnetic Modulation Biosensing (MMB), enables the development of point-of-care devices and consumable cartridges for applications in protein and specific DNA sequence detection, aiming to provide quick and accurate diagnostic results.
Frequently asked

What does MagBiosense do?

MagBiosense is focused on creating advanced diagnostic tools for rapid and highly sensitive detection of biomarkers. Their core technology, Magnetic Modulation Biosensing (MMB), enables the development of point-of-care devices and consumable cartridges for applications in protein and specific DNA sequence detection, aiming to provide quick and accurate diagnostic results.

Where is MagBiosense headquartered?

MagBiosense is headquartered in San Diego, United States.

When was MagBiosense founded?

MagBiosense was founded in 2013.

What industry does MagBiosense operate in?

MagBiosense operates in MedTech, Biotech, Diagnostics, Point-of-Care Diagnostics, Biomarker Detection, Medical Devices.

Comments

No comments yet. Be the first to share your take.